testosterone replacement therapy

From Monday's issue of The Press in York, England: A breast cancer patient from York says she is "disgusted" by a shortage of the drug she and hundreds of other women rely on to reduce the risk of the disease returning. Mother-of-two Marion Barclay, 45, said the situation became so serious last Friday, she faced the prospect of missing her daily dose of Arimidex tablets. This story is one of several reports on sporadic, worldwide shortages of Arimidex®, the brand of anastrozole sold by AstraZeneca. Anastrozole is a competitive inhibitor of the cytochrome P450 monooxygenase isozyme known as…